Showing 1811-1820 of 8826 results for "".
Personalized Skincare: What Women Want!
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/personalized-skincare-what-women-want/23750/A look at emerging approaches for delivering personalized skincare.In the Pipeline: New Approaches to Vitiligo, Congenital Ichthyosis, and More
https://practicaldermatology.com/topics/pigmentary-disorders/in-the-pipeline-new-approaches-to-vitiligo-congenital-ichthyosis-and-more/23714/Inflammatory diseases with few or no specific treatments may soon have approved interventions.What Dermatologists Should Know About Advocacy
https://practicaldermatology.com/topics/practice-management/what-dermatologists-should-know-about-advocacy/23678/The specialty needs advocacy. Here’s why and how to get involved.Disability Income Insurance: What Every Young Dermatologist Needs to Know
https://practicaldermatology.com/topics/practice-management/disability-income-insurance-what-every-young-dermatologist-needs-to-know/23597/Getting disability income insurance at an early age may offer lower rates and long-term peace of mind.In-person vs. Telehealth: Patient Preference and the Future of Engagement
https://practicaldermatology.com/topics/practice-management/in-person-vs-telehealth-patient-preference-and-the-future-of-engagement/23502/As Americans emerge from the pandemic, evidence suggests that patients may appreciate choices in how they interact with physicians.Preparing for the Future of Teledermatology
https://practicaldermatology.com/issues/supplements/preparing-for-the-future-of-teledermatology/23475/Telehealth served as an important stopgap for medical providers and their patients in the context of the COVID-19 pandemic, but will it persist? And if so, how can you derive the most benefit?Second Primary Tumors and Immune Checkpoint Inhibitors: What Do We Know?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/second-primary-tumors-and-immune-checkpoint-inhibitors-what-do-we-know/23452/New evidence reveals a potential link between ICI treatment and risk for secondary cancers.What You Should Know About Antibody Testing for SARS-CoV-2
https://practicaldermatology.com/topics/infections-infectious-disease/what-you-should-know-about-antibody-testing-for-sars-cov-2/23297/Here’s what we know about testing and its potential role for practices.Building for Tomorrow
https://practicaldermatology.com/topics/practice-management/building-for-tomorrow/23291/Tips for re-launching your practice post-COVID-19.Marketing Your Dermatology Practice During and After a Crisis
https://practicaldermatology.com/topics/practice-management/marketing-your-dermatology-practice-during-and-after-a-crisis/23273/Think twice about slashing or eliminating budgets for marketing. It is an essential lifeline for financial recovery.